ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,970.84
      -1.11%
      US Tech 100
      20,897.20
      -1.35%
      Dow Jones
      42,992.21
      -0.77%
      Brent Oil
      73.44
      0.00%
      Bitcoin
      94,218.71
      0.06%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Indices
      4. FTSE
      5. FTSE 350 Pharmaceuticals and Biotechnology Index (NMX201030)

      6. FTSE 350 Pharmaceuticals and Biotechnology Index (NMX201030) Financials

      NMX201030 FTSE 350 Pharmaceuticals and Biotechnology Index

      20,065.81
      9.91 (0.05%)
      Dec 27 2024 - Closed
      Delayed by 15 minutes
      Company name:FTSE 350 Pharmaceuticals and Biotechnology Index
      EPIC:NMX201030Trading Currency:GBP
      Market Sector:ISIN:
      Market Segment:Share Type:IX
      WWW Address:Description:
      Industry Sector:
       Price Price Change [%] Bid Ask Open High Low Volume
       20,065.81 images.advfn.com/imagesnew/2/us/up 9.91 [0.05] - - 20,055.90 20,076.72 19,930.15 -
       Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
       - - - - - - - 24,740.05 - 19,079.65

      FTSE 350 Pharmaceuticals... Key Figures

      Key Figures
      (at previous day's close)
      Market Cap.-m
      Shares In Issue-m
      Prev. Close20,055.90
      PE Ratio- 
      Dividend Yield-%
      EPS - basic-p
      Dividend PS-p
      Dividend Cover- 
      Cash Flow PS-p
      Return On Equity (ROE)-%
      Operating Margin-%
      PEG Factor- 
      EPS Growth Rate-%
      Dividends PS Growth Rate-%
      Net Debt-m
      Gross Gearing-%
      Quick Assets-m
      Net Working Capital-m
      Intangibles / Fixed Assets-%
      Turnover PS-p
      Pre-Tax Profit PS-p
      Retained Profit PS-p
      Cash PS-p
      Net Cash PS-p
      Net Tangible Asset Value PS *-p
      Net Asset Value PS-p
      Spread- (-%) 
      * Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

      FTSE 350 Pharmaceuticals... Balance Sheet

      %1$s Balance Sheet
      Sorry No Data Available

      Share Price Performance

      Share Price Performance
      Sample Period †HighLow
      1 week20,146.1119,465.79
      4 weeks20,583.6619,465.79
      12 weeks22,680.8619,079.65
      1 year24,740.0519,079.65

      Share Price Chart (5 years)

      Share Price Chart (5 years)

      FTSE 350 Pharmaceuticals... Historic Returns

      %1$s Historic Returns
      Giorni da oggi †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
      1 week19,748.41317.401.6119,465.79--
      4 weeks20,218.04-152.23-0.7519,465.79--
      12 weeks22,399.39-2,333.58-10.4219,079.65--
      26 weeks23,264.63-3,198.82-13.7519,079.65--
      1 year20,084.41-18.60-0.0919,079.65--
      3 years18,691.931,373.887.3517,366.64--
      5 years18,144.511,921.3010.59119.33--
      † periods calculated are whole weeks rather than calendar months

      FTSE 350 Pharmaceuticals... Key Management Ratios

      DEEPER ANALYSIS

      FTSE 350 Pharmaceuticals... Investment Ratios

      %1$s Investment Ratios
      (Market value analysis) at previous day's close
      PQ Ratio- 
      PE Ratio- 
      Tobin's Q Ratio - 
      Tobin's Q Ratio (excl. intangibles)- 
      Dividend Yield-%
      Market-to-Book Ratio- 
      Price-to-Pre-Tax Profit PS- 
      Price-to-Retained Profit PS- 
      Price-to-Cash Flow PS- 
      Price-to-Sales PS- 
      Price-to-Net Tangible Asset Value PS- 
      Price-to-Cash PS- 
      Net Working Capital PS- 
      Price Pct to Working Capital PS-%
      Earnings Yield-%
      Average PE- 
      Years in average- 
      PE to PE average-%

      FTSE 350 Pharmaceuticals... Financial Ratios

      %1$s Financial Ratios
      (Leverage Ratios)
      Debt Ratio-%
      Debt-to-Equity Ratio- 
      Debt-to-Equity Ratio (excl. Intgbl)- 
      Debt-to-Equity Market Value- 
      Net Gearing-%
      Net Gearing (excl. Intangibles)-%
      Gross Gearing-%
      Gross Gearing (excl. Intangibles)-%
      Gearing Under 1 Year-%
      Gearing Under 1 Year (excl. Intgbl)-%
      Assets/Equity- 
      Cash/Equity- 
      (Liquidity Ratios)
      Net Working Capital to Total Assets-%
      Current Ratio- 
      Quick Ratio (Acid Test)- 
      Liquidity Ratio- 
      Cash & Equiv/Current Assets-%
      (Solvency Ratios)
      Enterprise Value-m
      CFO/Sales- 
      CFO/Attributable Profit- 
      CFO/Assets- 
      CFO/Debt- 
      Total Debt/Equity Market Value- 
      Total Debt/Sales- 
      Total Debt/Pre-Tax Profit- 
      Total Debt-m
      Total Debt/Net Current Assets-%
      (Dodds - Graham Ratios)
      3 yr Compound Earnings Growth-%
      5 yr Compound Earnings Growth-%
      10 yr Compound Earnings Growth-%
      Earn drops > 5% in 10yrs- 
      Beta coefficients
      Beta (60-Mnth)Beta (36-Mnth)
      Sorry No Data AvailableSorry No Data Available

      FTSE 350 Pharmaceuticals... Operating Ratios

      %1$s Operating Ratios
      (Profitability Ratios)
      Return On Capital Employed (ROCE)-%
      Return On Assets (ROA)-%
      Net Profit Margin-%
      Assets Turnover- 
      Return On Equity (ROE)-%
      Return On Investment (ROI)-%
      Dividend Payout Ratio-%
      Plowback Ratio100.00%
      Growth from Plowback Ratio-%
      Net Income Of Revenues-%
      (Asset Utilisation Multiples)
      Shareholders Equity Turnover- 
      Fixed Assets Turnover- 
      Current Assets Turnover- 
      Net Working Capital Turnover 
      Inventory Turnover- 
      (Other Operating Ratios)
      Total Assets-to-Sales- 
      Debtors-to-Sales-%
      Debt Collection Period-Days

      FTSE 350 Pharmaceuticals... Dividends

      Sorry No Data Available

      FTSE 350 Pharmaceuticals... Fundamentals
      Sorry No Data Available

      FTSE 350 Pharmaceuticals... Balance Sheet

      Sorry No Data Available

      FTSE 350 Pharmaceuticals... Cash Flow Statement

      Sorry No Data Available

      FTSE 350 Pharmaceuticals... Brokers

      Broker infomation is not available for this class of share.

      Your Recent History

      FTSE
      NMX201030
      FTSE 350 Pharmaceuticals...
      Delayed Upgrade Clock